Search Results - "DAPOIGNY, M"

Refine Results
  1. 1

    Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome by Matricon, J., Meleine, M., Gelot, A., Piche, T., Dapoigny, M., Muller, E., Ardid, D.

    “…Summary Background Irritable bowel syndrome (IBS), one of the most common gastrointestinal disorders, markedly impairing patients' quality of life. Drug…”
    Get full text
    Journal Article
  2. 2

    Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study by Azpiroz, F., Dubray, C., Bernalier‐Donadille, A., Cardot, J.‐M., Accarino, A., Serra, J., Wagner, A., Respondek, F., Dapoigny, M.

    Published in Neurogastroenterology and motility (01-02-2017)
    “…Background Short‐chain fructooligosaccharides (scFOS) have beneficial effects in subjects with minor digestive complaints, but the potential mechanisms…”
    Get full text
    Journal Article
  3. 3

    The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota by Crouzet, L., Gaultier, E., Del'Homme, C., Cartier, C., Delmas, E., Dapoigny, M., Fioramonti, J., Bernalier‐Donadille, A.

    “…Background Alterations of intestinal microbiota and hypersensitivity to colonic distension are two features of the irritable bowel syndrome (IBS). However, the…”
    Get full text
    Journal Article
  4. 4

    Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome by Chassard, C., Dapoigny, M., Scott, K. P., Crouzet, L., Del'homme, C., Marquet, P., Martin, J. C., Pickering, G., Ardid, D., Eschalier, A., Dubray, C., Flint, H. J., Bernalier-Donadille, A.

    Published in Alimentary pharmacology & therapeutics (01-04-2012)
    “…Summary Background The role of the gut microbiota in patho‐physiology of irritable bowel syndrome (IBS) is suggested by several studies. However, standard…”
    Get full text
    Journal Article
  5. 5

    Comparative efficacy and safety of lactulose plus paraffin vs polyethylene glycol in functional constipation: a randomised clinical study by Piche, T, Dapoigny, M

    Published in United European gastroenterology journal (01-10-2020)
    “…Background Few head-to-head comparisons of the different classes of laxatives have been conducted. Objective The objective of this work is to compare the…”
    Get full text
    Journal Article
  6. 6

    Migraine prevalence in inflammatory bowel disease patients: A tertiary‐care centre cross‐sectional study by Moisset, X., Bommelaer, G., Boube, M., Ouchchane, L., Goutte, M., Dapoigny, M., Dallel, R., Guttmann, A., Clavelou, P., Buisson, A.

    Published in European journal of pain (01-10-2017)
    “…Background Inflammatory bowel diseases (IBD) are systemic, chronic inflammatory conditions that predominately affect the gastrointestinal tract and can induce…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Colonic overexpression of the T‐type calcium channel Cav3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients by Scanzi, J., Accarie, A., Muller, E., Pereira, B., Aissouni, Y., Goutte, M., Joubert‐Zakeyh, J., Picard, E., Boudieu, L., Mallet, C., Gelot, A., Ardid, D., Carvalho, F. A., Dapoigny, M.

    Published in Neurogastroenterology and motility (01-11-2016)
    “…Background Among the different mechanisms involved in irritable bowel syndrome (IBS) physiopathology, visceral hypersensitivity seems to play a key role. It…”
    Get full text
    Journal Article
  9. 9

    Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress by Darbaky, Y., Evrard, B., Patrier, S., Falenta, J., Garcin, S., Tridon, A., Dapoigny, M., Silberberg, C., Nivoliez, A., Diop, L.

    Published in Journal of applied microbiology (01-01-2017)
    “…Aims This study evaluated the efficacy of a repeated oral treatment with two active pharmaceutical ingredients (Lcr Lenio® and Lcr Restituo®) derivated from…”
    Get full text
    Journal Article
  10. 10

    Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome by Piche, T., Ducrotté, P., Sabate, J. M., Coffin, B., Zerbib, F., Dapoigny, M., Hua, M., Marine‐barjoan, E., Dainese, R., Hébuterne, X.

    Published in Neurogastroenterology and motility (01-06-2010)
    “…Background  Patients with irritable bowel syndrome (IBS) and Crohn disease (CD) have impaired quality of life (Qol) associated with fatigue. Whether IBS‐like…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Rectal Instillation of Butyrate Provides a Novel Clinically Relevant Model of Noninflammatory Colonic Hypersensitivity in Rats by Bourdu, Sophie, Dapoigny, Michel, Chapuy, Eric, Artigue, Fabrice, Vasson, Marie-Paule, Dechelotte, Pierre, Bommelaer, Gilles, Eschalier, Alain, Ardid, Denis

    Published in Gastroenterology (New York, N.Y. 1943) (01-06-2005)
    “…Background & Aims: The treatment of irritable bowel syndrome (IBS), characterized by abdominal pain and bloating, is empirical and often poorly efficient…”
    Get full text
    Journal Article
  13. 13

    Nutrition economics – characterising the economic and health impact of nutrition by Lenoir-Wijnkoop, I., Dapoigny, M., Dubois, D., van Ganse, E., Gutiérrez-Ibarluzea, I., Hutton, J., Jones, P., Mittendorf, T., Poley, M. J., Salminen, S., Nuijten, M. J. C.

    Published in British journal of nutrition (14-01-2011)
    “…There is a new merging of health economics and nutrition disciplines to assess the impact of diet on health and disease prevention and to characterise the…”
    Get full text
    Journal Article
  14. 14

    On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study by Ducrotte, P, Grimaud, J C, Dapoigny, M, Personnic, S, O'Mahony, V, Andro-Delestrain, M C

    “…In routine practice, irritable bowel syndrome (IBS) symptoms are often difficult to be relieved and impair significantly patients' quality of life (QoL). A…”
    Get more information
    Journal Article
  15. 15

    Colonic overexpression of the T-type calcium channel Cav 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients by Scanzi, J, Accarie, A, Muller, E, Pereira, B, Aissouni, Y, Goutte, M, Joubert-Zakeyh, J, Picard, E, Boudieu, L, Mallet, C, Gelot, A, Ardid, D, Carvalho, F A, Dapoigny, M

    Published in Neurogastroenterology and motility (01-11-2016)
    “…BACKGROUNDAmong the different mechanisms involved in irritable bowel syndrome (IBS) physiopathology, visceral hypersensitivity seems to play a key role. It…”
    Get full text
    Journal Article
  16. 16

    Colonic overexpression of the T-type calcium channel Ca v 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients by Scanzi, J, Accarie, A, Muller, E, Pereira, B, Aissouni, Y, Goutte, M, Joubert-Zakeyh, J, Picard, E, Boudieu, L, Mallet, C, Gelot, A, Ardid, D, Carvalho, F A, Dapoigny, M

    Published in Neurogastroenterology and motility (01-11-2016)
    “…Among the different mechanisms involved in irritable bowel syndrome (IBS) physiopathology, visceral hypersensitivity seems to play a key role. It involves…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome by SABATE, J.‐M., VEYRAC, M., MION, F., SIPROUDHIS, L., DUCROTTE, P., ZERBIB, F., GRIMAUD, J.‐C., DAPOIGNY, M., DYARD, F., COFFIN, B.

    Published in Alimentary pharmacology & therapeutics (15-08-2008)
    “…Summary Background  Relationships between pain threshold during rectal distension and both symptoms intensity and alteration in quality of life (QoL) in…”
    Get full text
    Journal Article
  19. 19

    Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial by Ducrotte, P., Dapoigny, M., Bonaz, B., Siproudhis, L.

    Published in Alimentary pharmacology & therapeutics (15-02-2005)
    “…Summary Background : Beidellitic montmorillonite is a purified clay containing a double aluminium and magnesium silicate. Aim : To assess the efficacy and the…”
    Get full text
    Journal Article
  20. 20